Rate this post


United Hashish (UCANN) holds U.S. Patent No. 9,730,911 that covers a cannabinoid-based medical product components invented by Tony Verzura and Earnie Blackmon. The patent issued August 15, 2017. UCANN filed go well with towards Pure Hemp in 2018 in Colorado federal court docket, alleging {that a} Pure Hemp product infringes sure claims of the ‘911 patent. This isn’t an extraction methodology patent: quite, this patent claims a selected formulation that could be produced by “any appropriate extraction methodology.” A sampling of the claims reads:

  1. A liquid cannabinoid formulation, whereby a minimum of 95% of the whole cannabinoids is cannabidiol ( CBD).
  2. A liquid cannabinoid formulation, whereby a minimum of 95% of the whole cannabinoids are THC [tetrahydrocannabinol] and CBD.
  3. A liquid cannabinoid formulation, whereby a minimum of 95% of the whole cannabinoids are CBD, cannabinol (CBN) and THC.

A full copy of the patent could be discovered right here.

Pure Hemp responded with an early movement for abstract judgment on the grounds that the asserted UCANN patent claims had been invalid and unenforceable below 35 U.C.S. 101 as a result of they’re directed at unpatentable subject material, i.e., naturally occurring cannabinoids. The District Court docket disagreed, holding that Pure Hemp “failed to determine past cheap dispute that the claimed UCANN formulations are something like a pure phenomenon.” I.e. UCANN’s patent claims survived. Pure Hemp’s early movement for partial abstract judgment was denied, and UCANN’s patent case towards Pure Hemp lives on.

So simply what number of cannabis associated patents have been filed in the US? Attempt greater than 10,000 since 1978, with greater than 6,000 filings since 2008. That’s lots of patent protection.

The clear message for the cannabis markets is that this – though cannabis could have been round for a very long time, the business markets and the IP portfolios which might be presently being constructed to erect boundaries to competitors in these markets haven’t. These boundaries are being erected as you learn this text. And, as gamers in additional conventional business markets can attest, patent litigation, even when profitable, could be costly sufficient to empty valuable capital and sink or significantly delay product launch. In a younger, aggressive and quickly rising market akin to the present cannabis market this might be a deadly blow.

What to do? Anybody within the cannabis markets can be effectively suggested to survey the sector of issued patents and revealed patent purposes to ensure that they perceive whether or not the present or potential enterprise operations could infringe another person’s IP. If there’s current IP that’s problematic, it might not be the tip of the world. Early discovery is the important thing to threat mitigation. At this early market stage it might be potential to barter licensing preparations, change plans for producing merchandise with a view to keep away from another person’s patent claims, or erect defenses to patent enforcement that can permit the enterprise to outlive and develop. Nevertheless, as soon as the patent holders are experiencing vital income and have consolidated their market place, they might not be very prepared to barter a fairly priced license. As an added incentive to patent looking, enterprise executives within the house must be conscious that failing to know the IP panorama earlier than utilizing investor’s cash may give rise to investor claims. The perfect method is to price range for patent looking and proactively interact competent patent counsel to uncover and disarm any patent points earlier than vital funds are dedicated, and earlier than that stop and desist letter reveals up within the mail.

The content material of this text is meant to supply a normal information to the subject material. Specialist recommendation must be sought about your particular circumstances.